Joshua M. Sharfstein

4.0k total citations
152 papers, 2.3k citations indexed

About

Joshua M. Sharfstein is a scholar working on General Health Professions, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Joshua M. Sharfstein has authored 152 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in General Health Professions, 36 papers in Economics and Econometrics and 33 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Joshua M. Sharfstein's work include Healthcare Policy and Management (20 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Public Health Policies and Education (18 papers). Joshua M. Sharfstein is often cited by papers focused on Healthcare Policy and Management (20 papers), Health Systems, Economic Evaluations, Quality of Life (18 papers) and Public Health Policies and Education (18 papers). Joshua M. Sharfstein collaborates with scholars based in United States, South Africa and Austria. Joshua M. Sharfstein's co-authors include Yngvild Olsen, Michelle M. Mello, Howard Bauchner, Margaret Hamburg, Janet Woodcock, Janet R. Serwint, Shannon Gwin Mitchell, Jerome H. Jaffe, Robert P. Schwartz and Jan Gryczynski and has published in prestigious journals such as Science, New England Journal of Medicine and The Lancet.

In The Last Decade

Joshua M. Sharfstein

138 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joshua M. Sharfstein United States	23	740	595	537	427	312	152	2.3k
Jennifer L. Ridgeway United States	22	504 0.7×	842 1.4×	578 1.1×	432 1.0×	188 0.6×	107	2.3k
Salomeh Keyhani United States	32	462 0.6×	1.0k 1.7×	632 1.2×	748 1.8×	286 0.9×	126	3.3k
Judy Wright United Kingdom	30	449 0.6×	652 1.1×	338 0.6×	348 0.8×	254 0.8×	113	2.6k
Rohina Joshi Australia	28	512 0.7×	782 1.3×	382 0.7×	379 0.9×	588 1.9×	143	2.8k
Maria Pisu United States	35	858 1.2×	709 1.2×	702 1.3×	1.1k 2.6×	657 2.1×	207	4.2k
Sania Nishtar United Kingdom	22	597 0.8×	696 1.2×	325 0.6×	548 1.3×	708 2.3×	93	2.7k
Christine Lainé United States	26	589 0.8×	816 1.4×	553 1.0×	381 0.9×	111 0.4×	97	3.1k
Johanna Anderson United States	22	403 0.5×	581 1.0×	327 0.6×	223 0.5×	102 0.3×	53	1.9k
Donna Shelley United States	31	1.1k 1.6×	1.5k 2.5×	373 0.7×	248 0.6×	184 0.6×	181	3.6k
Megan S. Schuler United States	25	447 0.6×	462 0.8×	535 1.0×	222 0.5×	244 0.8×	79	2.3k

Countries citing papers authored by Joshua M. Sharfstein

Since Specialization

Citations

This map shows the geographic impact of Joshua M. Sharfstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua M. Sharfstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua M. Sharfstein more than expected).

Fields of papers citing papers by Joshua M. Sharfstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua M. Sharfstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua M. Sharfstein. The network helps show where Joshua M. Sharfstein may publish in the future.

Co-authorship network of co-authors of Joshua M. Sharfstein

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua M. Sharfstein. A scholar is included among the top collaborators of Joshua M. Sharfstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua M. Sharfstein. Joshua M. Sharfstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharfstein, Joshua M., et al.. (2025). Vaccines and the 2024 US Presidential Election. JAMA Health Forum. 6(12). e255361–e255361.

Sharfstein, Joshua M.. (2025). The Value of Engagement and Transparency in Public Health Policymaking. JAMA Health Forum. 6(8). e254252–e254252.

Newman‐Toker, David E. & Joshua M. Sharfstein. (2024). The Role for Policy in AI-Assisted Medical Diagnosis. JAMA Health Forum. 5(4). e241339–e241339. 6 indexed citations

Sharfstein, Joshua M., et al.. (2023). US Community Pharmacies and Public Health—Building on the COVID-19 Response. JAMA Health Forum. 4(6). e232583–e232583. 5 indexed citations

Sharfstein, Joshua M., et al.. (2023). The Opioid Settlements—Will the First Steps Be in the Right Direction?. JAMA Health Forum. 4(9). e234017–e234017. 6 indexed citations

Sharfstein, Joshua M. & Nicole Lurie. (2023). Public Health Emergency Preparedness After COVID‐19. Milbank Quarterly. 101(S1). 653–673. 5 indexed citations

Sharfstein, Joshua M., et al.. (2022). Long-Acting Cabotegravir for HIV Prevention. JAMA. 327(10). 921–921. 18 indexed citations

Lurie, Nicole & Joshua M. Sharfstein. (2022). The New US National Biodefense Strategy—Necessary but Not Sufficient. JAMA Health Forum. 3(12). e225206–e225206. 1 indexed citations

Murphy, Karen, et al.. (2020). Resilience in Health Care Financing. JAMA. 324(2). 126–126. 6 indexed citations

10.

Ballreich, Jeromie, et al.. (2020). Affording Genetic Therapies in the Medicaid Program. JAMA Pediatrics. 174(6). 523–523. 4 indexed citations

11.

Sharfstein, Joshua M. & Christopher C. Morphew. (2020). The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020. JAMA. 324(2). 133–133. 46 indexed citations

12.

Sharfstein, Joshua M.. (2016). Flint, Michigan, and the Failure of Public Agencies. 1 indexed citations

13.

Sharfstein, Joshua M.. (2016). Banishing “Stakeholders”. Milbank Quarterly. 94(3). 476–479. 17 indexed citations

14.

Sharfstein, Joshua M.. (2015). Electronic Cigarettes: Gateway to Understanding the FDA?. Milbank Quarterly. 93(2). 251–254. 1 indexed citations

15.

Sharfstein, Joshua M.. (2014). The Public Health Challenge of Drug Overdose.

16.

Sharfstein, Joshua M.. (2014). A Global Epidemic in Plain Sight. 1 indexed citations

17.

Sharfstein, Joshua M.. (2013). Public Health Regulation as a Public Process. 1 indexed citations

18.

Sharfstein, Joshua M.. (2011). The FDA—A Misunderstood Agency. JAMA. 306(11). 1250–1250. 2 indexed citations

19.

Sharfstein, Joshua M.. (1998). 1996 congressional campaign priorities of the AMA: tackling tobacco or limiting malpractice awards?. American Journal of Public Health. 88(8). 1233–1236. 1 indexed citations

20.

Sharfstein, Joshua M. & Paul H. Wise. (1997). Inadequate hepatitis B vaccination of adolescents and adults at an urban community health center.. PubMed. 89(2). 86–92. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact